Glial Fibrillary Acidic Protein: Regulation by Hormones, Cytokines, and Growth Factors

Brain Pathology

Volumn 4, Issue 3, 1994, Pages 259-275

  Laping, Nicholas J ^a   Teter, Bruce ^a   Nichols, Nancy R ^a   Rozovsky, Irina ^a   Finch, Caleb E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; ANDROSTANOLONE; BASIC FIBROBLAST GROWTH FACTOR; CILIARY NEUROTROPHIC FACTOR; COLONY STIMULATING FACTOR 1; CORTICOSTERONE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL MATURATION FACTOR BETA; GLUCOCORTICOID; GROWTH FACTOR; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LIOTHYRONINE; STEROID HORMONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; RAT; REVIEW; TRANSCRIPTION REGULATION;

AGING; ANIMAL; ASTROCYTES; BASE SEQUENCE; BRAIN; BRAIN DISEASES; COMPARATIVE STUDY; CONSENSUS SEQUENCE; CYTOKINES; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HORMONES; HUMAN; MICE; MOLECULAR SEQUENCE DATA; RATS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION, GENETIC;

EID: 0028104020     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1994.tb00841.x     Document Type: Conference Paper

References (153)

1. Hypertrophy and redistribution of astrocytes in the deafferented dentate gyrus
2. The process of reinnervation in the dentate gyrus of adult rats: time course of increases in mRNA for glial fibrillary acidic protein
3. Variations in the neurotoxic potency of trimethyltin
4. TGF‐β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid‐induced neurodegeneration
5. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons
6. Synaptic regulation of glial protein expression in vivo
7. Molecular profile of reactive astrocytes ‐ implications for their role in neurologic disease
8. Dynamic neuronal‐glial interactions in hypothalamus and pituitary: Implications for control of hormone synthesis and release
9. Neuronal/glial plasticity in the supraoptic dendritic zone: dendritic bundling and double synapse formation at parturition
10. GFAP promoter directs astrocyte specific expression in transgenic mice
11. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes
12. Association of poly(A)RNA with microtubules in cultured neurons
13. Tumor necrosis factor‐induced proliferation of astrocytes from mature brain is associated with down‐regulation of glial fibrillary acidic protein mRNA
14. Expression of GFAP and neurofilament mRNA in gliosis induced by experimental autoimmune encephalomyelitis
15. Autoregulation of tubulin expression is achieved through the specific degradation of polysomal tubulin mRNAs
16. Cortical neurons inhibit basal and IL‐1 stimulated astroglial cell secretion of nerve growth factor
17. Cortical neurons selectively inhibit MHC class II induction in astrocytes but not in microglia cells
18. Vimentin, the 57000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia
19. Different intermediate‐sized filaments distinguished by immunofluorescence microscopy
20. Immunohistochemistry of nervous system specific antigens
21. The vimentin‐GFA protein transition in rat neuroglia cytoskeleton occurs at the time of myelination
22. Regulation of GFAP and its encoding mRNA in the developing brain and in cultured astrocytes
23. Gliogenesis in rat spinal cord: evidence for origin of astrocytes and oligodendrocytes from radial precursors
24. Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain
25. Temporal expression of mouse glial fibrillary acidic protein mRNA studied by a rapid in situ hybridization procedure
26. Developmental profile of GFAP in the rat brain: Increased regional GFAP following prenatal exposure to methylazoxymethanol
27. Age‐related changes in glial fibrillary acidic protein mRNA in the mouse brain
28. GFAP mRNA increases with age in rat and human brain
29. Alterations of glial fibrillary acidic protein mRNA in the aging brain and in senile dementia of the Alzheimer type
30. Hippocampal aging and adrenocorticoids: quantitative relations
31. Increased GFAP expression in the aged brain does not result from increased astrocytic density
32. Transcriptional regulation of glial fibrillary acidic protein (GFAP)‐mRNA expression during postnatal development of mouse brain
33. Developing forebrain astrocytes are sensitive to thyroid hormone
34. Synergistic action of thyroid hormone, insulin and hydrocortisone on astrocyte differentiation
35. The effects of neonatal hypothyroidism on rat brain gene expression
36. Messenger RNA for glial fibrillary acidic protein is decreased in rat brain following acute and chronic corticosterone treatment
37. Corticosterone differentially regulates the bilateral response of astrocyte mRNAs in the hippocampus to entorhinal cortex lesions in male rats
38. Glucocorticoids regulate the concentration of glial fibrillary acidic protein throughout the brain
39. Rapid corticosterone‐induced changes in gene expression in rat hippocampus display type II glucocorticoid receptor specificity
40. Changes in gene expression in hippocampus in response to glucocorticoids and stress
41. Adrenal hormones suppress cell division in the adult rat dentate gyrus
42. Expression of mineralocorticoid type I and glucocorticoid type II receptors in astrocyte glia as a function of time in culture
43. Type II glucocorticoid receptors are expressed in oligodendrocytes and astrocytes
44. Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury
45. Regulation of GFAP mRNA by glucocorticoids in vitro
46. Characterization of hormone response elements
47. Transcriptional interference between c‐Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein‐protein interaction
48. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element
49. Cell‐specific expression of the mouse glial fibrillary acidic protein gene: Identification of the cis‐ and trans‐acting promoter elements or astrocyte‐specific expression
50. Identification of a cis‐acting positive regulatory element of the glial fibrillary acidic protein gene
51. Estrogen receptor‐immunoreactive glia, endothelia, and ependyma in guinea pig preoptic area and median eminence: electron microscopy
52. Estradiol promotes cell shape changes and glial fibrillary acidic protein redistribution in hypothalamic astrocytes in vitro: A neuronal‐mediated effect
53. Estradiol‐induced redistribution of glial fibrillary acidic protein immunoreactivity in the rat brain
54. Natural fluctuations and gonadal hormone regulation of astrocyte immunoreactivity in dentate gyrus
55. Castration enhances expression of glial fibrillary acidic protein and sulfated glycoprotein‐2 in the intact and lesion‐altered hippocampus of the adult male rat
56. Gonadal steroids regulate the expression of glial fibrillary acidic protein in the adult male rat hippocampus
57. The distribution of glial fibrillary acidic protein in the adult rat brain is influenced by the neonatal levels of sex steroids
58. Sexual dimorphism in the hamster cerebellum demonstrated by glial fibrillary acidic protein (GFAP) and vimentin immunoreactivity
59. Metabolism and release of glutamate in cerebellar granule cells cocultured with astrocytes from cerebellum or cerebral cortex
60. Glucocorticoid suppression of lesion‐induced synaptogenesis: effect of temporal manipulation of steroid treatment
61. Neurotrophic effects of steroids on lesion‐induced growth in the hippocampus. I. The asteroidal condition
62. Short‐term glucocorticoid manipulations affect neuronal morphology and survival in the adult dentate gyrus
63. Hydrocortisone administration alters glial reaction to entorhinal lesion in the rat dentate gyrus
64. Plasticity of hippocampal circuitry in Alzheimer's disease
65. Neuroplasticity of the hippocampus and striatum: models for aging and neurodegenerative disease
66. Transforming growth factor‐β1 induces neuronal and astrocyte genes: Tubulin α1, glial fibrillary acidic protein, and clusterin
67. Distribution of androgen and estrogen receptor mRNA‐containing cells in the rat brain: an in situ hybridization study
68. Altered regulation of lesion induced synaptogenesis by adrenalectomy and corticosterone in young adult rats
69. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain
70. Cholinergic sprouting in the hippocampus: a proposed role for IL‐1
71. Detection of interleukin‐1 and interleukin‐6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production
72. Expression of interleukin (IL)‐1 beta, IL‐6 and their respective receptors in the normal rat brain and after injury
73. Transforming growth factor alpha contributes to the mechanism by which hypothalamic injury induces precocious puberty
74. Localization of cells containing transforming growth factor‐alpha precursor immunoreactivity in the basal ganglia of the adult rat brain
75. Increases in transforming growth factor‐beta mRNA in hippocampus during response to entorhinal cortex lesions in intact and adrenalectomized rats
76. Hypothesis: transforming growth factor‐β1 is an organizer of responses to neurodegeneration
77. Effects of interleukin‐1β and tumor necrosis factor‐α on the expression of glial fibrillary acidic protein and transferrin in cultured astrocytes
78. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines
79. Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria‐fornix transection
80. Involvement of cytokines in acute neurodegeneration in the CNS
81. Brain injury in a dish: a model or reactive gliosis
82. Transforming growth factor‐beta 1 (TGF‐β1) expression and regulation in rat cortical astrocytes
83. Glial cell‐specific mechanisms of TGF‐β1 induction by 11‐1 in cerebral cortex
84. Control of astrocytosis by interleukin‐1 and transforming growth factor‐B1 in human brain
85. IL‐1‐induced production of IL‐2 and IFN‐gamma in subclones of human T‐cell derived leukaemia HSB.2 cells: regulation by phytohaemag‐glutinin‐mediated (poly)phosphoinositide breakdown and cyclic AMP
86. Production of hemolymphopoietic cytokines (IL‐6, IL‐8, colony‐stimulating factors) by normal human astrocytes in response to IL‐1 beta and tumor necrosis factor‐alpha
87. Induction and regulation of interleukin‐6 gene expression in rat astrocytes
88. Transforming growth factor beta's inhibit mitogen‐stimulated proliferation of astrocytes
89. Transforming growth factor‐beta inhibition of interleukin‐1 activity involves down‐regulation of interleukin‐1 receptors on chondrocytes
90. Transforming growth factor‐beta suppresses activation and proliferation of microglia in vitro
91. Transforming growth factor‐β1 mRNA decreases in brain in response to glucocorticoid treatment of adrenalectomized rats
92. Effects of transforming growth factor‐β1 on the extracellular matrix and cytoskeleton of cultured astrocytes
93. Serum and transforming growth factor beta regulate glial fibrillary acidic protein in serum‐free‐derived mouse embryo cells
94. Establishment of an astrocyte progenitor cell line: Induction of glial fibrillary acidic protein and fibronectin by transforming growth factor‐beta 1
95. Expression of a TGF beta regulated, brain‐specific mRNA in serum‐free mouse embryo (SFME) cells
96. Transforming growth factor‐beta induces cytoskeleton and extracellular matrix modifications in FRTL‐5 thyroid epithelial cells
97. Expression of platelet‐derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors
98. Transforming growth factor‐beta alters differentiation in cultures of avian neural crest‐derived cells: effects on cell morphology, proliferation, fibro‐nectin expression, and melanogenesis
99. Effects of transforming growth factor type beta on expression of cytoskeletal proteins in endosteal mouse osteoblastic cells
100. Deposition of scar tissue in the central nervous system
101. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes
102. Enhanced expression of transforming growth factor (31 in the rat brain after localized cerebral injury
103. Glialspecific cAMP response of the glial fibrillary acidic protein gene in the RT4 cell lines
104. TGF‐β1 induces phosphorylation of the cyclic AMP responsive element binding protein in ML‐CC164 cells
105. Fibroblast growth factor (FGF): a multifunctional growth factor in the CNS
106. Transforming growth factor‐beta 1 stimulates macrophage urokinase expression and release of matrix‐bound basic fibroblast growth factor
107. Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of human prostate‐derived fibroblasts
108. Reactive astrogliosis after basic fibroblast growth factor (bFGF) injection in injured neonatal rat brain
109. Primary cultures of astrocytes from different brain areas of newborn rats and effects of basic fibroblast growth factor
110. lnterleukin‐1 injected into mammalian brain stimulates astrogliosis and neovascularization
111. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
112. Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture
113. Prolonged delivery of transgene products to specific brain regions by migratory astrocyte grafts
114. Multiple interacting sites regulate astrocyte specific transcription of the human gene for glial fibrillary acidic protein
115. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor‐β
116. Regulation of the al(l) collagen promoter via a transforming growth factor‐β activation element
117. Autoinduction of transforming growth factor β1 is mediated by the AP‐1 complex
118. Analysis of a segment of the human glial fibrillary acidic protein gene that directs astrocyte‐specific transcription
119. Evidence that an additional conserved element with the consensus (C/G)AG(A/C) is essential for maximal responsiveness of the cAMP enhancer
120. AP‐1 complex and c‐fos transcription are involved in TPA provoked and tran‐synaptic induction of the tyrosine hydroxylase gene: insights into long‐term regulatory mechanisms
121. Intragenic sequences affect the expression of the gene encoding glial fibrillary acidic protein
122. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐KB transcription factor and HIV‐1
123. A labile repressor acts through the NFKB‐like binding sites of the human urokinase gene
124. Acute phase response factor, a nuclear factor binding to acute‐phase response elements, is rapidly activated by IL‐6 at the transcriptional level
125. Multiple cis‐ and trans‐acting elements mediate the transcriptional response to phorbol esters
126. Delay of astrocyte reaction in the injured cerebral cortex of hypothyroid mouse
127. How embryos work: a comparative view of diverse modes of cell fate specification
128. Human B cell growth factor enhances proliferation and glial fibrillary acidic protein gene expression in rat astrocytes
129. Influence of epidermal growth factor on the maturation of fetal rat brain cells in aggregate culture. An immunocytochemical study
130. Expression of glial fibrillary acidic protein in human medulloblastoma cells treated with recombinant glia maturation factor‐β
131. Regulation of glial fibrillary acidic protein in serum‐free mouse embryo (SMFE) cells by leukemia inhibitory factor and related peptides
132. Common DNA binding site for fos protein complexes and transcription factor AP‐1
133. Structural determinants of a glucocorticoid receptor recognition element
134. TGF‐β1 inhibition of transin/stromolysin gene expression is mediated through a fos binding sequence
135. In vitro interaction of uterine receptor with the estrogen response element present in the 3′‐flanking region of the murine c‐fos protooncogene
136. Analysis of the DNA‐binding and activation properties of the human transcription factor AP‐2
137. Involvement of the nuclear factor I motif in the mouse myelin basic protein promoter in cell‐specific regualtion: comparison witht he mouse glial fibrillary acidic protein promoter
138. Multiple hormone response elements can confer glucocorticoid regulation on the human insulin receptor gene
139. Purification of a protein doublet that binds to six TGG‐containing sequenes in the promoter for hamster 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase
140. Characterization of human cDNA and genomic clones for glial fibrillary acidic protein
141. Acute‐phase response factor, a nuclear factor binding to acute‐phase response elements, is rapidly activated by interleukin‐6 at the posttranslational level
142. Detection of brain‐specific gene expression in primary cell culture: a novel promoter bases on use of a retrovirus assay